Source:http://linkedlifedata.com/resource/pubmed/id/16178894
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
4
|
| pubmed:dateCreated |
2005-9-23
|
| pubmed:abstractText |
To investigate the usefulness of immunohistochemical expression and immunolocalization of a panel of thyroid malignancy markers including HBME-1, cytokeratin (CK) 19 and galectin-3.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Oct
|
| pubmed:issn |
0309-0167
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
47
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
391-401
|
| pubmed:dateRevised |
2010-10-19
|
| pubmed:meshHeading | |
| pubmed:year |
2005
|
| pubmed:articleTitle |
Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy.
|
| pubmed:affiliation |
Department of Pathology, Division of Endocrinology, School of Medicine (FCM), State University of Campinas (UNICAMP), Sao Paulo, Brazil. pasmatos@fcm.unicamp.br
|
| pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|